C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity
Bhuvaneish T Selvaraj,Matthew R Livesey,Chen Zhao,Jenna M Gregory,Owain T James,Elaine M Cleary,Amit K Chouhan,Angus B Gane,Emma M Perkins,Owen Dando,Simon G Lillico,Youn-Bok Lee,Agnes L Nishimura,Urjana Poreci,Sai Thankamony,Meryll Pray,Navneet A Vasistha,Dario Magnani,Shyamanga Borooah,Karen Burr,David Story,Alexander McCampbell,Christopher E Shaw,Peter C Kind,Timothy J Aitman,C Bruce A Whitelaw,Ian Wilmut,Colin Smith,Gareth B Miles,Giles E Hardingham,David J A Wyllie,Siddharthan Chandran
DOI: https://doi.org/10.1038/s41467-017-02729-0
2018-01-24
Abstract:Mutations in C9ORF72 are the most common cause of familial amyotrophic lateral sclerosis (ALS). Here, through a combination of RNA-Seq and electrophysiological studies on induced pluripotent stem cell (iPSC)-derived motor neurons (MNs), we show that increased expression of GluA1 AMPA receptor (AMPAR) subunit occurs in MNs with C9ORF72 mutations that leads to increased Ca2+-permeable AMPAR expression and results in enhanced selective MN vulnerability to excitotoxicity. These deficits are not found in iPSC-derived cortical neurons and are abolished by CRISPR/Cas9-mediated correction of the C9ORF72 repeat expansion in MNs. We also demonstrate that MN-specific dysregulation of AMPAR expression is also present in C9ORF72 patient post-mortem material. We therefore present multiple lines of evidence for the specific upregulation of GluA1 subunits in human mutant C9ORF72 MNs that could lead to a potential pathogenic excitotoxic mechanism in ALS.